However, in low-tuberculosis-incidence European countries, immunocompromised patients have a relatively low risk of active tuberculosis unless there is a clear history of exposure to M. tuberculosis and ongoing HIV replication with low CD4 counts (Sester et al., 2025). This evidence concerns the gene CD4 and tuberculosis.